Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, July 14, 2023.
Boston Scientific received FDA approval for image-guided programming software, advancing deep brain stimulation treatments for neurological conditions. Fast Five hosts Sean Whooley and Danielle Kirsh review what the software offers clinicians.
Henry Schein recently secured a $750 million credit facility, fueling its growth and ability to provide quality products and services in the medical device industry. Learn about the credit facility’s maturity, what executives are saying, and some of the busy strategic moves the company made earlier this week.
Aerin Medical’s treatment for nasal airway obstruction gained support with data validation, offering effective solutions for improved breathing and quality of life. Whooley and Kirsh discuss what VivAer is and some of the key data points from the study and what doctors think of the device.
Inogen recently expanded its respiratory care portfolio by acquiring Physio-Assist, a French developer of airway clearance technology. Hear about Physio-Assist’s business and what Inogen’s rationale was behind the acquisition.
BD highlighted the importance of medical device cybersecurity, disclosing and addressing eight vulnerabilities in the Alaris infusion systems. The Fast Five hosts explain which devices are included in the vulnerabilities and the rocky history of Alaris pumps in the last few years.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
